Daniel Ben-Mordechay: Portal Vein Thrombosis – Ultrasound Perspective
Daniel Ben-Mordechay, Chief Executive Officer at Orimed GTD, shared a post on LinkedIn:
“Portal Vein Thrombosis (PVT): Ultrasound Perspective
Portal vein thrombosis is a key cause of prehepatic portal hypertension, resulting from partial or complete obstruction of the portal vein lumen by thrombus formation.
Clinically, PVT may be asymptomatic, particularly in chronic settings, and is often detected incidentally during imaging follow-up in patients with underlying liver disease.
However, in acute cases, it may present with abdominal pain or signs related to mesenteric venous involvement.
From an imaging standpoint, multiple modalities can be used for diagnosis and characterization, including CT and MRI.
Nevertheless, ultrasound remains the first-line imaging modality due to its availability, safety, and real-time assessment capabilities.
Ultrasound findings:
- Gray-scale imaging
Acute PVT typically appears as echogenic or heterogeneous material within the portal vein lumen. The vein may appear distended compared to normal, especially in early stages.
- Color Doppler evaluation
The hallmark finding is partial or complete absence of flow within the portal vein. In some cases, reduced or altered flow patterns may be observed rather than complete absence.
- Chronic PVT considerations
In longstanding cases, cavernous transformation may develop, characterized by multiple serpiginous collateral vessels replacing the normal portal vein.
From a POCUS perspective, recognizing the combination of intraluminal material and absent or abnormal Doppler flow is critical for raising suspicion and prompting further evaluation.
Early identification has direct clinical implications, particularly in guiding anticoagulation, evaluating underlying etiologies, and preventing complications such as portal hypertension and bowel ischemia.”
Stay updated with Hemostasis Today.
-
Sep 24, 2026, 08:55Andres Gudino: Clot Characterization Through Hounsfield Units in Ischemic Stroke
-
Sep 24, 2026, 06:52Gina Sado: Screening-Detected Atrial Fibrillation Carries High Risk of Heart Failure
-
Sep 24, 2026, 06:33Benjamin Vipler: Optimal Oral Anticoagulation Choice in Atrial Fibrillation and Advanced CKD
-
Sep 24, 2026, 06:08Christopher Salerno: AI-Powered At-Home Anemia Screening Advances Telehealth Access
-
Sep 24, 2026, 05:38Aya Qattan: When a Normal CBC Does Not Mean Normal Iron Status
-
Sep 24, 2026, 05:11Mastering Warm Autoimmune Hemolytic Anemia Diagnosis and Practice – ASH Education
-
Sep 23, 2026, 16:04Monia Ezzalfani: Advancing Patient-Centered Care in Hemophilia A and B
-
Sep 23, 2026, 15:49Bilge Başak: How Activated PRP Modulates Osteoarthritic Chondrocyte Function
-
Sep 23, 2026, 14:50Mbonjo Bitsie Dora: Strengthening Sickle Cell Care Through Education, Awareness and Innovation